Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
NGS-Based RNA-Sequencing Market Size, Value And Growth Trajectory Through 2030
The ngs-based rna-sequencing market has experienced significant expansion in recent years. It is anticipated to grow from $4.2 billion in 2025 to $5.27 billion in 2026, achieving a compound annual growth rate (CAGR) of 25.3%. Historically, this growth has been driven by the expansion of genomic research initiatives, declining cost of sequencing technologies, increased use of rna-seq in academic research, availability of advanced sequencing platforms, and the growth of bioinformatics capabilities.
The ngs-based rna-sequencing market size is anticipated to experience significant growth in the coming years. It is projected to expand to $12.73 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 24.7%. This projected growth throughout the forecast period stems from factors such as the increasing adoption of rna sequencing in clinical diagnostics, rising investments in precision medicine, the expansion of pharmaceutical research applications, a growing demand for integrated data analysis solutions, and an increasing focus on multi-omics research. Major trends influencing this period include the rising adoption of high-throughput rna sequencing platforms, an increasing demand for single-cell rna sequencing, the growing utilization of cloud-based bioinformatics analysis, the expansion of transcriptomics in precision medicine, and an enhanced focus on data accuracy and scalability.
Get A Free Sample Report With In-Depth Market Insights:
NGS-Based RNA-Sequencing Market Development Factors: What’s Supporting Demand?
The expanding pharmaceutical sector is anticipated to fuel the growth of the NGS-based RNA-sequencing market in the future. This industry encompasses the entire process of discovering, developing, and manufacturing drugs and medications, undertaken by both government and private organizations. NGS-based RNA-sequencing is employed by the pharmaceutical industry for in-depth analysis of gene expression, pinpointing potential drug targets, evaluating how drugs interact, and unraveling disease mechanisms. This advanced technique enhances drug discovery and development by providing a profound insight into molecular processes. For instance, data from June 2025, as reported by the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, showed that prescription drug outlays increased by 11.4% in 2023, reaching $449.7 billion, which was an acceleration from the 7.8% growth recorded in 2022. Consequently, the expansion of the pharmaceutical industry is a significant impetus behind the growth of the NGS-based RNA-sequencing market.
NGS-Based RNA-Sequencing Market Segmentation And Category Overview
The ngs-based rna-sequencing market covered in this report is segmented –
1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management
2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing
3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly
4) By End User: Research & Academia, Pharmaceutical & Biotechnology Companies, Other End Users
Subsegments:
1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents
2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables
3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services
4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms
NGS-Based RNA-Sequencing Market Transformation Trends: What Innovations Are Driving Change?
Leading companies within the NGS-based RNA-sequencing market are prioritizing the creation of innovative products, such as advanced small RNA-seq kits, to optimize processes and enhance the precision and effectiveness of RNA expression analysis. These cutting-edge library preparation solutions are engineered to precisely isolate and sequence minute RNA molecules with high accuracy. They assist researchers in expediting research procedures, mitigating unwanted byproducts like adapter dimers, and obtaining more dependable and consistent expression profiles. For Instance, in October 2025, Lexogen, an Austria-based biotechnology company, launched the miRVEL Profiling Small RNA-Seq Library Prep Kit, specifically designed to streamline and enhance small RNA research workflows. This groundbreaking kit offers an expedited and dependable process, enabling the preparation of sequencing-ready libraries in under seven hours with minimal hands-on effort. It incorporates sophisticated adapter blocking mechanisms to avert the creation of adapter dimers, guarantees consistent outcomes irrespective of input quantity, and includes built-in 8 nt unique dual indices (UDIs) for accurate multiplexing and read assignment. The miRVEL Profiling Kit caters to diverse research applications, including RNA interference studies, host-defense mechanism investigations, and plant or agricultural small RNA research. Additionally, it integrates seamlessly with Lexogen’s SPLIT RNA extraction kits and TraPR small RNA enrichment system, offering a comprehensive, complete solution for small RNA analysis.
NGS-Based RNA-Sequencing Market Competitive Overview And Top Companies
Major companies operating in the ngs-based rna-sequencing market are Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Takara Bio Inc., GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Genohub LLC, BaseClear B.V., Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.
View The Full NGS-Based RNA-Sequencing Market Report:
NGS-Based RNA-Sequencing Market Leading Geography: Which Region Contributes The Most Revenue?
North America was the largest region in the NGS-based RNA sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model